Platelet and megakaryocyte CD40L expression in β-Thalassemic patients
- 2 March 2020
- journal article
- letter
- Published by Elsevier BV in Thrombosis Research
- Vol. 189, 108-111
- https://doi.org/10.1016/j.thromres.2020.02.026
Abstract
No abstract availableKeywords
Funding Information
- Istituto Superiore di Sanità
- Ministero della Salute
This publication has 8 references indexed in Scilit:
- Thalassemia and the hypercoagulable stateThrombosis Research, 2013
- Early Growth Response-1 (EGR-1) and Nuclear Factor of Activated T Cells (NFAT) Cooperate to Mediate CD40L Expression in Megakaryocytes and PlateletsOnline Journal of Public Health Informatics, 2013
- Hypercoagulability in β-thalassemia: a status quoExpert Review of Hematology, 2012
- Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytesBlood, 2008
- Soluble CD40LCirculation, 2003
- CD40 Is Constitutively Expressed on Platelets and Provides a Novel Mechanism for Platelet ActivationCirculation Research, 2003
- CD40-CD40L and Platelet FunctionCirculation Research, 2003
- Soluble CD40 Ligand in Acute Coronary SyndromesThe New England Journal of Medicine, 2003